| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/22/2014 | CA2753700C Anti-rhesus d monoclonal antibody |
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/22/2014 | CA2703279C Antibody purification by cation exchange chromatography |
| 04/22/2014 | CA2609234C Anti-il2 antibodies |
| 04/22/2014 | CA2595906C Libraries and methods for isolating antibodies |
| 04/22/2014 | CA2580620C Method of detecting hepatitis b virus s antigen |
| 04/22/2014 | CA2527795C Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 04/22/2014 | CA2519258C Construct comprising region recognized by antibody against von willebrand factor-specific cleaving protease |
| 04/22/2014 | CA2398998C Cd40-binding apc-activating molecules |
| 04/22/2014 | CA2394357C Modified leukotoxin gene and protein |
| 04/17/2014 | WO2014059028A1 Anti-c16orf54 antibodies and methods of use thereof |
| 04/17/2014 | WO2014059002A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to phosphinothricin-n-acetyl-transferase |
| 04/17/2014 | WO2014058947A1 Compositions and methods for treating cancer using pi3k inhibitor and anti-cd19 maytansinoid immunoconjugate |
| 04/17/2014 | WO2014058924A2 Antibodies recognizing alpha-synuclein |
| 04/17/2014 | WO2014058875A2 Combination therapies and uses for treatment of demyelinating disorders |
| 04/17/2014 | WO2014058389A1 Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics |
| 04/17/2014 | WO2014057687A1 Antibody-drug conjugate |
| 04/17/2014 | WO2014057528A1 Method for detecting squamous cell carcinoma |
| 04/17/2014 | WO2014057129A1 THE DETECTION OF FREE AND PROTEIN-BOUND NON-HUMAN GAL-α-(1→3)-GAL EPITOPE |
| 04/17/2014 | WO2014057122A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| 04/17/2014 | WO2014057118A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| 04/17/2014 | WO2014057115A1 Pyrrolobenzodiazepine-anti-her2 antibody conjugates |
| 04/17/2014 | WO2014056934A1 Modulator of quinolinic acid for use in the treatment of a neuropathological disease |
| 04/17/2014 | WO2014056816A1 COMBINATION OF AN Aβ ANTIBODY AND A BACE INHIBITOR |
| 04/17/2014 | WO2014056783A1 Fc-free antibodies comprising two fab-fragments and methods of use |
| 04/17/2014 | WO2014031859A3 Compositions and methods relating to blood-based biomarkers of breast cancer |
| 04/17/2014 | WO2014031694A3 Anti-tau antibodies and methods of making and using in treatment of tauopathies |
| 04/17/2014 | WO2014030096A3 Genes and processes for the production of clavine-type alkaloids |
| 04/17/2014 | WO2014030052A3 Compositions comprising an antibody and camostat mesylate (cm) |
| 04/17/2014 | WO2013191146A9 Kit for diagnosing malignant melanoma |
| 04/17/2014 | WO2013153457A3 Rapid test for cellular fibronectin |
| 04/17/2014 | WO2013109279A3 Stabilization of the anti-cd20 antibody rituximab |
| 04/17/2014 | WO2013052155A9 Methods of treating liver conditions using notch2 antagonists |
| 04/17/2014 | WO2013030831A3 Pathogen and substance traps |
| 04/17/2014 | WO2012125495A3 Method of correlated mutational analysis to improve therapeutic antibodies |
| 04/17/2014 | US20140106404 Method for producing heterologous protein using yeast with disruption of vps gene |
| 04/17/2014 | US20140105998 Treatment of diseases |
| 04/17/2014 | US20140105917 Frizzled-binding agents and uses thereof |
| 04/17/2014 | US20140105916 Human c-fms antigen binding proteins |
| 04/17/2014 | US20140105915 Bcma (cd269/tnfrsf17) - binding proteins |
| 04/17/2014 | US20140105914 Humanised anti ctla-4 antibodies |
| 04/17/2014 | US20140105913 Immunoglobulin constant region fc receptor binding agents |
| 04/17/2014 | US20140105910 Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins |
| 04/17/2014 | US20140105909 Sclerostin antibody crystals and formulations thereof |
| 04/17/2014 | US20140105907 Anti-cd40 antibody mutants |
| 04/17/2014 | US20140105906 Peptide for Protection of Allergic Respiratory Disorders |
| 04/17/2014 | US20140105905 High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies |
| 04/17/2014 | US20140105904 Anthrax and small pox replikins and methods of use |
| 04/17/2014 | US20140105903 Modulators of Plexin B2 Activity |
| 04/17/2014 | US20140105902 Use of lrig1 as a biomarker for identifying a subject for application of anti-c-met antibodies |
| 04/17/2014 | US20140105901 Use of cbl as biomarker for identifying subject suitable for treatment with anti-c-met antibody |
| 04/17/2014 | US20140105900 Methods and compositions relating to anti-il-21 receptor antibodies |
| 04/17/2014 | US20140105899 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 04/17/2014 | US20140105897 Novel Anti-IL13 Antibodies and Uses Thereof |
| 04/17/2014 | US20140105896 Fibronectin based scaffold domain proteins that bind to myostatin |
| 04/17/2014 | US20140105894 Humanized anti-il-18 antibodies |
| 04/17/2014 | US20140105890 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide |
| 04/17/2014 | US20140105889 Method for altering plasma retention and immunogenicity of antigen-binding molecule |
| 04/17/2014 | US20140105888 Novel modulators and methods of use |
| 04/17/2014 | US20140105860 Engineered antibody-tnfsf member ligand fusion molecules |
| 04/17/2014 | US20140105821 Antibody that stops or slows tumour growth (variants) |
| 04/17/2014 | DE112012000404T5 Modulatoren von IL-12 und/oder IL-23 zur Prävention oder Behandlung des Morbus Alzheimer Modulators of IL-12 and / or IL-23 for the prevention or treatment of Alzheimer's disease |
| 04/16/2014 | EP2719709A1 The detection of free and protein-bound non-human Gal-alpha(1-3)-Gal epitope |
| 04/16/2014 | EP2719708A2 Material and methods for treating or preventing HER-3 associated diseases |
| 04/16/2014 | EP2719704A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method |
| 04/16/2014 | EP2718726A1 Diagnostic use of prosomatostatin |
| 04/16/2014 | EP2718435A1 Sema5b peptides and vaccines including the same |
| 04/16/2014 | EP2718428A1 Rabies virus like particle production in plants |
| 04/16/2014 | EP2718327A1 Mcam antagonists and methods of treatment |
| 04/16/2014 | EP2718326A1 Antibodies against g-csfr and uses thereof |
| 04/16/2014 | EP2718325A1 Anti-psgl-1 antibodies and uses thereof |
| 04/16/2014 | EP2718324A1 Binding compounds to human 1-adrenoreceptor ( 1-ar) and their use in the measurement of auto-anti- a1-ar antibodies |
| 04/16/2014 | EP2718323A2 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor |
| 04/16/2014 | EP2718322A1 Therapeutic antibodies |
| 04/16/2014 | EP2718321A1 Anti-ricin antibodies and uses thereof |
| 04/16/2014 | EP2718320A2 Anti-pseudomonas psl binding molecules and uses thereof |
| 04/16/2014 | EP2717911A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer |
| 04/16/2014 | EP2717908A1 Cetp fragments |
| 04/16/2014 | CN103732628A Multivalent heteromultimer scaffold design and constructs |
| 04/16/2014 | CN103732627A Marker for diagnosing liver cancer containing anti-ATIC autoantibody, and composition for diagnosing liver cancer containing antigen thereof |
| 04/16/2014 | CN103732626A Anti-PSGL-1 antibodies and uses thereof |
| 04/16/2014 | CN103732625A Inhibition of bone resorption with RANKL binding peptides |
| 04/16/2014 | CN103732624A Anti-angptl3 antibodies and uses thereof |
| 04/16/2014 | CN103732623A Antibodies specific for TGF-beta |
| 04/16/2014 | CN103732622A Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 04/16/2014 | CN103732621A Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 04/16/2014 | CN103732620A Therapeutic canine immunoglobulins and methods of using the same |
| 04/16/2014 | CN103732619A Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders |
| 04/16/2014 | CN103732252A Combination therapy with an anti - CD19 antibody and a nitrogen mustard |
| 04/16/2014 | CN103725698A Surface protein ClfA gene segment of chemically-synthesized staphylococcus aureus as well as expression and application of surface protein ClfA gene segment |
| 04/16/2014 | CN103725697A Chemically synthesized staphylococcus aureus surface protein FnBPA gene fragment and expression and application thereof |
| 04/16/2014 | CN103724434A Recombination protein for detection of virus of porcine reproductive and respiratory syndrome and preparation method and application thereof |
| 04/16/2014 | CN103724433A Humanized anti-factor d antibodies and uses thereof |
| 04/16/2014 | CN103724432A Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 ) |
| 04/16/2014 | CN103724431A Humanized anti-CD26 antibody and application thereof |
| 04/16/2014 | CN103724430A Anti mif antibodies |
| 04/16/2014 | CN103724429A Preparation method of anti-piglet diarrhea IgY (immunoglobulin of yolk) |
| 04/16/2014 | CN103724413A B cell epitope 8A1 of trichina paramyosin and application thereof |
| 04/16/2014 | CN103724402A Complement function related antigen epitope and antibody of trichina paramyosin |
| 04/16/2014 | CN103275222B Monoclonal antibody for blocking 12p40 function of interleukin as well as coding gene and application thereof |